Output Explorer

PROGRESS REPORT 10
Totelle Img
Client: Wyeth
August 16, 2002
PROJECT
CLASSIFICATION
TARGET
STATUS / ACTION
PUBLICATION
DATE/JOURNAL
Poster A6
Endometrium/safety
WMC
A comparative 2-year study of two
Berlin, June 2002
Poster presented
sequential regimens of Img estradiol
and trimegestone with 1 mg estradiol
and norethisterone upon profiles of
endometrial bleeding and safety in
postmenopausal women
P.Koninckx, D. Spielmann and the
Trimegestone 302 Study Group
Poster A7
Metabolic
WMC
Blood lipid profiles in
postmenopausal women on either a
impact/hemostasis
Berlin, June 2002
Poster presented
sequential regimen of Img estradiol
and trimegestone or 1 mg estradiol
and norethisterone over a 1-year
period
P. Koninckx, D. Spielmann and the
Trimegestone 302 Study Group
Poster A8
Hemostasis
WMC
Berlin, June 2002
Poster presented
A 1-year comparative assessment of
the hemostatic profile of
postmenopausal women following a
sequential regimen of Img estradiol
combined with either trimegestone or
norethisterone
C. Kluft , D. Spielmann and the
Trimegestone 302 Study Group
PAPERS FOR WMC SYMPOSIUM PROCEEDINGS
nparative clinical evaluation of
Bone
WMC
the effect of a new sequential HRT
Berlin, June 2002
First draft submitted for initial review 30.07.02
preparation containing 2 m
estradiol and the progestin
trimegestone on postmenopausal
bone loss
M. Gambacciani
A comparative clinical evaluation of
WMC
a continuous HRT preparation
Climacteric symptoms
Efficacy
Berlin, June 2002
First draft submitted for initial review 9.08.02
containing 1 mg estradiol and the
novel progestin trimegestone
P. Bouchard
An overview of the comparative
WMC
efficacy, safety, bleeding profile and
effect on lipids of a sequential HRT
Berlin, June 2002
t draft submitted for initial review 1.08.02
preparation containing 2 mg
estradiol and trimegestone
H.P.G. Schneider
The preclinical biology of
WMC
trimegestone: a new potent and
Berlin, June 2002
First draft submitted for initial review 29.07.02
selective progestin
R. Winneker
PAPERS FOR PROGESTIN SYMPOSIUM
Confidential Pursuant to Confidentiality
OLIVS020-007893
Order
Source: https://www.industrydocuments.ucsf.edu/docs/ylvw0217

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.